How many years of comparable data are there for Democratic Republic of Congo and New Zealand?

25 years are reported by both, from 2000 to 2024.

Where does this data come from?

UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Democratic Republic of Congo vs New Zealand: Access to anti-retroviral drugs, female

Democratic Republic of Congo

78.0%

in 2024

New Zealand

80.0%

in 2024

Democratic Republic of Congo rank

60th

New Zealand rank

57th

Access to anti-retroviral drugs, female over time

Democratic Republic of Congo
New Zealand

How they compare

New Zealand currently reports 80.0% against 78.0% in Democratic Republic of Congo, a difference of 2.0%.

The two have swapped places 2 times across 25 shared years of data; in 2000 it was New Zealand ahead.

Democratic Republic of Congo ranks 60th and New Zealand ranks 57th of 141 countries.

New Zealand has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade	Democratic Republic of Congo	New Zealand	Difference	Ahead
2000s	2.0%	47.5%	45.5%	New Zealand
2010s	25.7%	64.6%	38.9%	New Zealand
2020s	70.2%	73.8%	3.6%	New Zealand

Averages of every year both report within each decade.

Frequently asked questions

Which has higher access to anti-retroviral drugs, female, Democratic Republic of Congo or New Zealand?: New Zealand, at 80.0% against 78.0% in Democratic Republic of Congo as of 2024.
What is the difference in access to anti-retroviral drugs, female between Democratic Republic of Congo and New Zealand?: 2.0%, with New Zealand ahead.
How many years of comparable data are there for Democratic Republic of Congo and New Zealand?: 25 years are reported by both, from 2000 to 2024.
How do Democratic Republic of Congo and New Zealand rank globally for access to anti-retroviral drugs, female?: Democratic Republic of Congo ranks 60th and New Zealand ranks 57th of 141 countries.
Where does this data come from?: UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Democratic Republic of Congo vs New Zealand: Access to anti-retroviral drugs, female. Statizoid, drawing on UNAIDS estimates. Retrieved 17 September 2026, from https://gender.statizoid.com/compare/access-to-anti-retroviral-drugs-female-percent/congo-dem-rep/new-zealand/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/compare/access-to-anti-retroviral-drugs-female-percent/congo-dem-rep/new-zealand/">Democratic Republic of Congo vs New Zealand: Access to anti-retroviral drugs, female</a> — Statizoid

About this data

Indicator: Access to anti-retroviral drugs, female (%)
Unit: %
Source: UNAIDS estimates
Licence: CC BY 4.0 (World Bank Open Data)
Coverage: 160 places, 3,925 data points, 2000–2024
Last refreshed: 04 September 2026

The percentage of adult females living with HIV who are receiving antiretroviral therapy.